New Mixed Standard for Stevia Testing to JECFA Protocol

IRVINE, Calif., May 25, 2011 /PRNewswire/ -- ChromaDex Corporation (OTCBB: CDXC), a world leader in phytochemical reference standards and contract research, announces the addition of a new stevia standard to its reference standard offering. Laboratories doing stevia analysis will now have one complete reference standard that contains all nine of the compounds needed to perform an analysis of the extract obtained from the leaves of Stevia rebaudiana Bertoni using the latest Joint FAO/WHO Expert Committee on Food Additives (JECFA) method.

"ChromaDex is at the forefront of providing the latest testing methodologies for stevia and stevia compounds. We have now developed the only complete mixed standard that contains all of the stevia compounds required for the JECFA method," stated Frank Jaksch, CEO and co-founder of ChromaDex. "We are committed to serving the stevia raw material market with the materials and technologies needed to insure fast accurate test results."

About ChromaDex

ChromaDex is a world leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. ChromaDex is committed to sustainable, "green chemistry" and provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the analytical tools, products, and services to meet the regulatory, quality, efficacy and safety standards for their products. To learn more, visit www.ChromaDex.com.

Forward-Looking Statements

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Investor Inquiries:
Liviakis Financial Communications, Inc.
John M. Liviakis, President
415-389-4670
[email protected]

ChromaDex Contact
Laura Carney
Executive Assistant to the CEO, President, and CFO
10005 Muirlands Blvd, Suite G, Irvine, CA 92618
949-419-0288
[email protected]

Media Inquiries:
Carolyn Hawley
Canale Communications
619-849-5375
[email protected]

SOURCE ChromaDex Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED